» Articles » PMID: 31501416

TRPM8-androgen Receptor Association Within Lipid Rafts Promotes Prostate Cancer Cell Migration

Overview
Journal Cell Death Dis
Date 2019 Sep 11
PMID 31501416
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

In prostate carcinogenesis, androgens are known to control the expression of the transient receptor potential melastatin 8 (TRPM8) protein via activation of androgen receptor (AR). Overexpression and/or activity of TRPM8 channel was shown to suppress prostate cancer (PCa) cell migration. Here we report that at certain concentrations androgens facilitate PCa cell migration. We show that underlying mechanism is inhibition of TRPM8 by activated AR which interacts with the channel within lipid rafts microdomains of the plasma membrane. Thus, our study has identified an additional nongenomic mechanism of the TRPM8 channel regulation by androgens that should be taken into account upon the development of novel therapeutic strategies.

Citing Articles

TRPM channels in human cancers: regulatory mechanism and therapeutic prospects.

Liu Q, Hu M, Li S, Zhang X, Zhang R, Lyu H Biomark Res. 2024; 12(1):152.

PMID: 39633507 PMC: 11616203. DOI: 10.1186/s40364-024-00699-2.


Residues of TRPM8 at the Lipid-Water-Interface have Coevolved with Cholesterol Interaction and are Relevant for Diverse Health Disorders.

Shikha D, Dalai R, Kumar S, Goswami C J Membr Biol. 2024; 257(5-6):345-364.

PMID: 39150496 PMC: 11584472. DOI: 10.1007/s00232-024-00319-y.


Paxillin regulates androgen receptor expression associated with granulosa cell focal adhesions.

Weidner A, Roy A, Vann K, Walczyk A, Astapova O Mol Hum Reprod. 2024; 30(5).

PMID: 38718206 PMC: 11136451. DOI: 10.1093/molehr/gaae018.


Roles of TRPM channels in glioma.

Chen Z, Xie H, Liu J, Zhao J, Huang R, Xiang Y Cancer Biol Ther. 2024; 25(1):2338955.

PMID: 38680092 PMC: 11062369. DOI: 10.1080/15384047.2024.2338955.


Prostate Cancer and the Mevalonate Pathway.

Guerrero-Ochoa P, Rodriguez-Zapater S, Anel A, Esteban L, Camon-Fernandez A, Espilez-Ortiz R Int J Mol Sci. 2024; 25(4).

PMID: 38396837 PMC: 10888820. DOI: 10.3390/ijms25042152.


References
1.
Yang Z, Wang X, Wang H, Hu L . Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells. Asian J Androl. 2009; 11(2):157-65. PMC: 3735032. DOI: 10.1038/aja.2009.1. View

2.
Cunha G, Donjacour A, Cooke P, Mee S, Bigsby R, Higgins S . The endocrinology and developmental biology of the prostate. Endocr Rev. 1987; 8(3):338-62. DOI: 10.1210/edrv-8-3-338. View

3.
Stenman U, Leinonen J, Zhang W, Finne P . Prostate-specific antigen. Semin Cancer Biol. 1999; 9(2):83-93. DOI: 10.1006/scbi.1998.0086. View

4.
Asuthkar S, Elustondo P, Demirkhanyan L, Sun X, Baskaran P, Velpula K . The TRPM8 protein is a testosterone receptor: I. Biochemical evidence for direct TRPM8-testosterone interactions. J Biol Chem. 2014; 290(5):2659-69. PMC: 4317017. DOI: 10.1074/jbc.M114.610824. View

5.
Foradori C, Weiser M, Handa R . Non-genomic actions of androgens. Front Neuroendocrinol. 2007; 29(2):169-81. PMC: 2386261. DOI: 10.1016/j.yfrne.2007.10.005. View